Evidence map›Paper›PMID 42584810›Full record

ArticleDiscover nano2026

Large language models accelerated health informatics screening framework predicts infrared triggered drug delivery performance of doped hydroxyapatite.

Olumakinde Charles Omiyale, Svetlana Aleksandrovna Ulasevich

Abstract read
In one paragraph

Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Olumakinde Charles OmiyaleInfochemistry Unit, ITMO University, Saint Petersburg, Russia, 191002. oomiiale@itmo.ru.
Svetlana Aleksandrovna UlasevichInfochemistry Unit, ITMO University, Saint Petersburg, Russia, 191002.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal-doped hydroxyapatite (HA) is an excellent material for infrared (IR)-induced on-demand drug delivery applications. However, conventional methods for predicting the optoelectronic and photothermal properties of metal-doped hydroxyapatite require intensive computational efforts using density functional theory (DFT). In this work, we show that fine-tuned large language models, namely Darwin 1.1.5 (a question- answering and multitask fine-tuned LLaMA-7 B model with 28,000 scientific QA pairs and 21 FAIR datasets, including NagasawaOPV and QM 9 datasets with SMILES encoding) and an optical property predictor based on T5, can achieve state-of-the-art accuracy with MAD and RMSE of 0.72 eV and 0.69 eV for bandgap prediction, respectively, compared to PBE- DFT (MAD= 1.65 eV) and GNN predictors (RMSE ≈ 0.85 eV), while reducing the time cost by an estimated 50-70%. The proposed system operates as an evidence-based characterization tool and decision support system, proven by predicting a monotonically decreasing trend in bandgap as the doping concentration increases: the Ag-HA series goes from 4.312 eV (0.25 mol %) to 3.983 eV (0.75 mol %); the Au-HA series from 4.300 to 3.950 eV; the Ti- HA series from 4.000 to 3.600 eV; the Zn-HA series from 4.680 to 4.400 eV; and the Mg-HA series from 4.600 to 4.500 eV, all consistent with hybrid-functional DFT benchmarks. T5 simulations show quadratically increasing absorption between 808 nm (0.5-1.3 a.u. for 1-2 mol % Ag and Au) and plasmonic SPR peaks at 420-432 nm. The predicted photothermal conversion efficiency is 34.7 ± 2% for Ag-HA, while at 445 nm it is 18.8%. On the other hand, NIR-induced tetracycline release from Ag-HA reaches 39.21 ± 2.2.5% at 10 min, which is 2.15 times that of passive diffusion (Computational estimate yet to be verified experimentally). All dopants exhibit substitutional doping at Ca

Indexed as

AI accelerated screeningBandgap predictionDarwin 1.5Density functional theoryHydroxyapatiteInfrared-triggered drug deliveryLarge language modelsMaterials informaticsNanomedicinePhotothermal therapySilver nanoparticlesSMILES

Identifiers

PMID42584810
PMCPMC13469274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.